Maspin expression in human gastric adenocarcinoma

Area of Science:

• Oncology
• Molecular Biology
• Gastroenterology

Background:

• Maspin, a serpin family protease inhibitor, is recognized as a tumor suppressor.
• The precise role of maspin expression in human cancers, particularly gastric adenocarcinoma, requires further elucidation.

Purpose of the Study:

• To investigate maspin expression patterns in gastric adenocarcinoma and its relationship with non-carcinoma gastric epithelia.
• To determine the correlation between maspin protein and mRNA expression levels in gastric tissues.

Main Methods:

• Immunohistochemistry was employed to assess maspin protein expression in 30 gastric adenocarcinoma cases.
• Reverse transcription-polymerase chain reaction (RT-PCR) was used to quantify maspin mRNA levels.
• Gastric epithelial cells with intestinal metaplasia (GECIM) and non-metaplastic, non-carcinoma gastric epithelia (NMNCE) were also analyzed.

Main Results:

• Maspin showed diffuse and strong immunoreactivity in 90% of gastric adenocarcinomas and all GECIM cases.
• NMNCE exhibited weak and focal maspin immunoreactivity in 69.2% of cases.
• Maspin mRNA levels were significantly higher in gastric adenocarcinoma compared to non-carcinoma mucosa (P < 0.001).
• A correlation was observed between lower maspin mRNA expression rates and maspin underexpression via immunohistochemistry (P < 0.001).

Conclusions:

• Maspin expression is significantly altered in gastric adenocarcinoma and GECIM.
• The findings suggest that maspin may play a role in gastric carcinogenesis.
• Immunohistochemical maspin expression appears to accurately reflect its mRNA expression levels.